The goal of this work is to develop nasal formulations of THA based on bovine serum albumin nanoparticles (NPL BSA) with -cyclodextrin (CD) and some of its derivatives such as hydroxypropyl -cyclodextrin (HPCD) and sulphobutyl ether -cyclodextrin (SBECD), as permeation enhancers (2,3). Thermal analysis supported by FTIR spectroscopy was used for solid-state characterization of NPL BSA systems. Powders were characterized for drug content, morphology, size distribution and surface charge, as well as for mucoadhesion properties and ex-vivo drug permeation ability.
ALBUMIN NANOPARTICLES CARRYING PERMEATION ENHANCERS FOR NASAL DELIVERY OF TACRINE HYDROCHLORIDE / B. Luppi; F. Bigucci; G. Corace; T. Cerchiara; M. Sorrenti; L. Catenacci; A.M. Di Pietra; G. Bettinetti; V. Zecchi. - STAMPA. - (2010), pp. 105-106. (Intervento presentato al convegno Meeting on Lactose as a Carrier for Inhalation Products tenutosi a Parma nel 26-28 september 2010).
ALBUMIN NANOPARTICLES CARRYING PERMEATION ENHANCERS FOR NASAL DELIVERY OF TACRINE HYDROCHLORIDE
LUPPI, BARBARA;BIGUCCI, FEDERICA;CORACE, GIUSEPPE;CERCHIARA, TERESA;DI PIETRA, ANNA MARIA;ZECCHI, VITTORIO
2010
Abstract
The goal of this work is to develop nasal formulations of THA based on bovine serum albumin nanoparticles (NPL BSA) with -cyclodextrin (CD) and some of its derivatives such as hydroxypropyl -cyclodextrin (HPCD) and sulphobutyl ether -cyclodextrin (SBECD), as permeation enhancers (2,3). Thermal analysis supported by FTIR spectroscopy was used for solid-state characterization of NPL BSA systems. Powders were characterized for drug content, morphology, size distribution and surface charge, as well as for mucoadhesion properties and ex-vivo drug permeation ability.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
